Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production.

This article is protected by copyright. All rights reserved.
PMID: 31054259 [PubMed - as supplied by publisher]

Source: European Journal of Immunology - May 3, 2019 Category: Allergy & Immunology Authors: Kozicky LK, Menzies SC, Hotte N, Madsen KL, Sly LM Tags: Eur J Immunol Source Type: research